WHO Edges Closer To Finalizing "Biological Qualifier" Proposal
This article was originally published in SRA
The final version of the World Health Organization's plan for a "biological qualifier" for all biological medicines could be adopted by the end of this year if agreement is reached on the latest draft during a meeting this week.
You may also be interested in...
Companies marketing dexamethasone in Europe have been told they can use a CHMP endorsement to request the addition of COVID-19 to their product license.
A “powerful new vision” for the post-Brexit UK regulatory framework was unveiled at a conference organized by the BioIndustry Association and the medicines regulator, the MHRA.
InflaRx and Relief Therapeutics/NeuroRx are investigating potential new treatments for COVID-19-induced pneumonia and for coronavirus-related ARDS.